CompletedPhase 4NCT02555540

Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses

Studying Whooping cough

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Ghent
Principal Investigator
Geert Leroux-Roels, Prof., MD
Center for Vaccinology
Intervention
Boostrix(biological)
Enrollment
240 enrolled
Eligibility
18-45 years · All sexes
Timeline
20152016

Study locations (1)

Collaborators

University of Surrey · Novartis Vaccines · Max Planck Institute for Infection Biology · deCODE genetics · GlaxoSmithKline · Sanofi Pasteur, a Sanofi Company · Innovative Medicines Initiative

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02555540 on ClinicalTrials.gov

Other trials for Whooping cough

Additional recruiting or active studies for the same condition.

See all trials for Whooping cough

← Back to all trials